Research on organic solar cells has been conducted for a long time. Recent advancements in understanding their molecular ...

An international team led by scientists of GSI/FAIR in Darmstadt, Johannes Gutenberg University Mainz and the Helmholtz Institute Mainz, succeeded in determining the chemical properties of the ...

(Nanowerk News) Research on organic solar cells has been conducted for a long time. Recent advancements in understanding their molecular structures are now paving the way for the development of highly ...

Ocrevus is a medicine commonly used to treat primary progressive MS, but it can take up to four hours to receive intravenously. A new version called “Ocrevus Zunovo” was recently approved by ...

Roche has said it plans to UK price its latest multiple sclerosis drug Ocrevus in line with its close rival from Novartis - aiming to undercut some established rivals. Approved in Europe earlier ...

We used a two-step extraction process to isolate as diverse chemical mixtures as possible," says Georg Braun, postdoctoral researcher in Beate Escher's working group and first author of the study.

A subcutaneous (SC) injection version of Roche’s big-selling multiple sclerosis therapy Ocrevus has matched the current intravenous form in a clinical trial and, according to the company ...

You see on the left side with Ocrevus and Evrysdi ... So, trontinemab is indeed, as Azad nicely pointed out, a novel molecular entity. So, it’s a so-called Brainshuttle A-beta antibody.

Big Pharma is sticking to the recent molecular glue investment trend, with Pfizer now the latest major drugmaker to get in on the action. Pfizer is laying out $49 million upfront in a partnership ...

But no one knew whether they might work as a team to enter an egg, or how. In the new study, Andrea Pauli, a molecular and developmental biologist at the Research Institute of Molecular Pathology ...